Renaud Roy1, Janice Ma2. 1. , PharmD, MSc, is a Pharmacist with the Hôpital général juif Sir Mortimer B. Davis, Montréal, Quebec. 2. , BScPharm, PharmD, is a Drug Use Evaluation Pharmacist with Canadian Forces Health Services Group Headquarters, Ottawa, Ontario.
Abstract
BACKGROUND: Spontaneous reports of adverse drug reactions (ADRs) form an essential component of both drug safety monitoring and patient safety initiatives. Pharmacists are well positioned to report ADRs, but many barriers exist to their doing so. Over the past decade, substantial changes have occurred with regard to drug regulations and medication safety initiatives, and it is possible that knowledge-based interventions may be needed to enhance ADR reporting by pharmacists. OBJECTIVE: To determine whether ADR reporting behaviours of pharmacists improved after release of a revised policy on the reporting of medication incidents. METHODS: A telephone survey was administered to pharmacists practising in the Canadian Forces Health Services Group. Self-reported behaviours and perceived barriers related to ADR reporting were compared before and 3 months after the updated policy was released. Accuracy in participants' self-assessed ADR reporting was evaluated using independently derived workload statistics. RESULTS: During the second survey phase (after release of the revised policy), a greater proportion of respondents reported awareness of institutional policies on ADR reporting and declared that they were able to complete all necessary ADR reports during their assigned work hours. However, the number of ADR reports submitted did not increase. Participants' recall of their ADR reporting behaviour was corroborated by workload data. During the second survey phase, there was a noticeable reduction in the number of free-form comments mentioning lack of staff as a barrier to ADR reporting. CONCLUSIONS: Release of a more comprehensive policy was not associated with an increase in the number of ADR reports generated by pharmacists in the study setting. Interventions to strengthen the organization's work processes for detection of ADRs and submission of individual ADR reports should be strongly considered, to reinforce and enhance existing ADR reporting behaviours among pharmacists.
BACKGROUND: Spontaneous reports of adverse drug reactions (ADRs) form an essential component of both drug safety monitoring and patient safety initiatives. Pharmacists are well positioned to report ADRs, but many barriers exist to their doing so. Over the past decade, substantial changes have occurred with regard to drug regulations and medication safety initiatives, and it is possible that knowledge-based interventions may be needed to enhance ADR reporting by pharmacists. OBJECTIVE: To determine whether ADR reporting behaviours of pharmacists improved after release of a revised policy on the reporting of medication incidents. METHODS: A telephone survey was administered to pharmacists practising in the Canadian Forces Health Services Group. Self-reported behaviours and perceived barriers related to ADR reporting were compared before and 3 months after the updated policy was released. Accuracy in participants' self-assessed ADR reporting was evaluated using independently derived workload statistics. RESULTS: During the second survey phase (after release of the revised policy), a greater proportion of respondents reported awareness of institutional policies on ADR reporting and declared that they were able to complete all necessary ADR reports during their assigned work hours. However, the number of ADR reports submitted did not increase. Participants' recall of their ADR reporting behaviour was corroborated by workload data. During the second survey phase, there was a noticeable reduction in the number of free-form comments mentioning lack of staff as a barrier to ADR reporting. CONCLUSIONS: Release of a more comprehensive policy was not associated with an increase in the number of ADR reports generated by pharmacists in the study setting. Interventions to strengthen the organization's work processes for detection of ADRs and submission of individual ADR reports should be strongly considered, to reinforce and enhance existing ADR reporting behaviours among pharmacists.
Entities:
Keywords:
adverse reactions; drug monitoring; organization and administration; pharmacists
Authors: Paul Gavaza; Carolyn M Brown; Kenneth A Lawson; Karen L Rascati; James P Wilson; Mary Steinhardt Journal: Br J Clin Pharmacol Date: 2011-07 Impact factor: 4.335
Authors: Bc Carleton; Rl Poole; Ma Smith; Js Leeder; R Ghannadan; Cjd Ross; Ms Phillips; Mr Hayden Journal: Pharmacoepidemiol Drug Saf Date: 2009-08 Impact factor: 2.890
Authors: Candace Necyk; Ross T Tsuyuki; Heather Boon; Brian C Foster; Don Legatt; George Cembrowski; Mano Murty; Joanne Barnes; Theresa L Charrois; John T Arnason; Mark A Ware; Rhonda J Rosychuk; Sunita Vohra Journal: BMJ Open Date: 2014-03-28 Impact factor: 2.692
Authors: Eveline B Boeker; Monica de Boer; Jordy J S Kiewiet; Loraine Lie-A-Huen; Marcel G W Dijkgraaf; Marja A Boermeester Journal: BMC Health Serv Res Date: 2013-09-28 Impact factor: 2.655